PER 1.23% 8.0¢ percheron therapeutics limited

re: Ann: Change of Director's Interest No... Rare stuff attracts...

  1. 13,916 Posts.
    lightbulb Created with Sketch. 124
    re: Ann: Change of Director's Interest No... Rare stuff attracts orphan status attracts quicker (smaller trials etc) and longer commercialisation.

    I think it's a good strategy for capital constrained microcap Biotechs.

    Among other things I'm impressed with the longevity of their IP, especially given their two most advanced drugs are mid to late stage.

    If things go to plan they will have well over 10 years exclusivity in the market.



 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.